Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls

Fig. 1

An overview of the study. Study design (A). Differentially expressed proteins between unstimulated and stimulated CD4+ T cells (B). Differentially expressed proteins between HC and MS in unstimulated CD4+ T cells (C) and in stimulated CD4+ T cells (D). Proteins that change in abundance upon CD4+ T cell activation of samples from MS and HC (E). The Venn diagram displays the number of proteins that were differentially expressed between unstimulated and stimulated CD4+ T cells from HCs (blue) and MS patients (red)

Back to article page